FTUS
ABBV icon

Flow Traders U.S.’s AbbVie ABBV Stock Holding History

Flow Traders U.S.’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$900K Buy
+4,139
New +$918K 0.03% 487
2025
Q1 		– Sell
-5,133
Closed -$912K – 895
2024
Q4 		$912K Buy
+5,133
New +$944K 0.04% 417

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flow Traders U.S.'s ABBV Position: Q1 2026 in Review

Flow Traders U.S. opened a new position in AbbVie (ABBV) in Q1 2026: 4,139 shares worth $900K. The stake represents 0.03% of the portfolio and ranks #487 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in ABBV as recently as Q4 2024.

Flow Traders U.S. first reported a position in ABBV in Q4 2024 and has held it in 2 quarters since. The position peaked at $912K in Q4 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Flow Traders U.S. held 4,139 shares of AbbVie worth $900K as of Q1 2026.
  • AbbVie was a new Flow Traders U.S. position in Q1 2026.
  • AbbVie made up 0.03% of Flow Traders U.S.'s portfolio in Q1 2026, its #487 holding.
  • Flow Traders U.S. first reported a position in AbbVie in Q4 2024 and has held it in 2 quarters since.
  • Flow Traders U.S.'s AbbVie position peaked at $912K in Q4 2024.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.